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Fatty Acid Supplementation 
Reverses the Small Colony Variant 
Phenotype in Triclosan-Adapted 
Staphylococcus aureus: Genetic, 
Proteomic and Phenotypic 
Analyses
Abdulrahman S. Bazaidͷ,͸, Sarah Forbes͹, Gavin J. Humphreysͷ, Ruth G. Ledderͷ, Ronan 
O’Cualainͺ & Andrew J. McBain  ͷ
Staphylococcus aureus can develop a small colony variant (SCV) phenotype in response to sub-lethal 
exposure to the biocide triclosan. In the current study, whole genome sequencing was performed 
and changes in virulence were investigated in ive Staphylococcus aureus strains following repeated 
exposure to triclosan. Following exposure, ͺ/ͻ formed SCV and exhibited point mutations in the 
triclosan target gene fabI with ͸/ͺ SCVs showing mutations in both fabI and fabD. The SCV phenotype 
was in all cases immediately reversed by nutritional supplementation with fatty acids or by repeated 
growth in the absence of triclosan, although fabI mutations persisted in ͹/ͺ reverted SCVs. Virulence, 
determined using keratinocyte invasion and Galleria mellonella pathogenicity assays was signiicantly 
(p < Ͷ.Ͷͻ) attenuated in ͹/ͺ SCVs and in the non-SCV triclosan-adapted bacterium. Proteomic analysis 
revealed elevated FabI in ͸/͹ SCV and down-regulation in a protein associated with virulence in ͷ/͹ 
SCV. In summary, attenuated keratinocyte invasion and larval virulence in triclosan-induced SCVs 
was associated with decreases in growth rate and virulence factor expression. Mutation occurred in 
fabI, which encodes the main triclosan target in all SCVs and the phenotype was reversed by fatty acid 
supplementation, demonstrating an association between fatty acid metabolism and triclosan-induced 
SCV.
Staphylococcus aureus causes a wide range of community and hospital acquired infections1. Coupled with the 
colonisation of almost a third of the general population2, the ability to cause recurrent infections, and antibiotic 
resistance, S. aureus treatment is increasingly challenging. In some reports, recurrent S. aureus infections have 
been associated with the emergence of small colony variants (SCVs), a slow-growing subpopulation of bacteria3,4. 
Although there are conlicting reports about the antibiotic susceptibility and comparative virulence of S. aureus 
SCVs, reduced antibiotic susceptibility in SCVs associated with prolonged antibiotic therapy such as aminogly-
cosides has been reported5. In addition to reduced growth rates, the SCV phenotype may be modulated during 
infection and the expression of virulence factors regulated accordingly, thus promoting persistence and survival 
within host cells6–9.
According to previous reports, S. aureus can form SCVs following exposure to sub-lethal concentrations of 
the phenolic biocide, triclosan10,11, which is commonly used for disinfection and hygiene purposes. Triclosan has 
ͷDivision of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, 
Stopford Building, The University of Manchester, Manchester, UK. ͸College of Applied Medical Sciences, University 
of Hail, Hail, Saudi Arabia. ͹Biomolecular Sciences Research Centre, Sheield Hallam University, Sheield, UK. 
ͺBiological Mass Spectrometry Core Facility, Faculty of Biology, Medicine and Health, The University of Manchester, 
Manchester, UK. Correspondence and requests for materials should be addressed to A.J.M. (email: andrew.mcbain@
manchester.ac.uk)
Received: 5 October 2017
Accepted: 6 February 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCIENTIFIC REPORTS |  (2018) 8:3876  | DOI:ͷͶ.ͷͶ͹8/sͺͷͻ98-Ͷͷ8-͸ͷ9͸ͻ-ͼ
broad-spectrum antibacterial activity, with the major mode of action involving the disruption of fatty acid biosyn-
thesis through the inhibition of the enoyl-acyl protein reductase enzyme FabI at bacteriostatic concentrations12. 
According to some reports, triclosan also directly targets the bacterial cell membrane13,14 although disruption in 
fatty acid synthesis may also indirectly afect cell membrane integrity.
he formation of gentamicin-induced S. aureus SCVs has been attributed to a mutation in the electron trans-
port chain genes, menD and hemB7 resulting in auxotrophy for these growth factors. In contrast, triclosan-induced 
SCVs may not be deicient in any of these growth factors and as such their emergence could be due to impaired 
energy production10.
he chacteristics of triclosan-induced SCV have been previously investigated for S. aureus ATCC 683511 where 
the SCVs showed reduced pathogenicity in an invertebrate model and exhibited decreased hemolysis, coagulase 
and DNase production11. his triclosan-induced SCV also exhibited defects in cell division overexpression of the 
triclosan target enzyme (FabI)15. However, whilst the emergence of S. aureus SCVs during antibiotic exposure 
has been previously investigated, comparatively little is known about the mechanisms resulting in the formation 
of SCVs in response to triclosan, or the implications of adaptation. he aim of the current study therefore was 
to explore genomic alterations and reversibility in triclosan-adapted S. aureus SCVs. Additionally, to expand 
the previous observations11,15, relative pathogenicity and cell invasion were assessed in a panel of SCVs and a 
non-SCV forming strain. Protein expression was also investigated to gain further insights into the phenotypic 
alterations associated with triclosan adaptation.
Results
Development of the SCV phenotype. Ater triclosan exposure (P10), 4/5 strains (ATCC 43300, NCTC 
13277, SAR17 and Newman) formed the SCV phenotype as evidenced by the formation of pinpoint colonies. 
he colony morphology of strain SAR2831 remained unchanged. In all cases, the SCV phenotype was unstable, 
reverting following ive or more passages in the absence of triclosan.
Mutations in S. aureus SCVs. Single non-synonymous mutations in the fabI gene were observed in P10 
and PX10 SCVs for Newman, NCTC13277 and SAR17 strains (Table 1), where cytosine (C) changed to thymine 
(T) leading to an amino acid change (A95V). his mutation was sustained when triclosan was removed (PX10) 
although compensatory mutations were not detected. ATCC 43300 exhibited a diferent fabI single nucleotide 
polymorphism (G113C). A mutation was also identiied in the fabD gene of both ATCC 43300 (V111D) and the 
Newman strain (Q228K) following exposure to triclosan. he latter mutation was also observed in the Newman 
strain ater recovery in the absence of triclosan (PX10). Teicoplanin resistance associated membrane gene (tcaA) 
exhibited a mutation (G373V) in the triclosan exposed non-SCV strain SAR2831which was also observed in 
PX10.
Triclosan induced SCVs revert with fatty acid supplementation. he Newman S. aureus strain and 
the SCV derived from ATCC43300 showed the largest reduction in colony size when comparing P10 to the 
original parent strains (21% and 24% respectively; p < 0.001) while SCV derived from SAR17 and NCTC13277 
colonies were almost 50% (p < 0.02) the size of the wild-type strain. When SCVs were supplemented with fatty 
acids, they underwent full phenotypic reversion (p < 0.05) in the SCV phenotype (Fig. 1).
Reduced triclosan susceptibility in S. aureus SCV. Table 2 illustrates the susceptibility of S. aureus to 
triclosan following triclosan exposure. Strains exhibiting the SCV phenotype (derived from ATCC 43300, NCTC 
13277, SAR17 and the Newman strain) exhibited a signiicant decrease (p < 0.05) in sensitivity to triclosan at MIC 
and MBC. his contrasts with the non-SCV strain, SAR2831, which exhibited no signiicant change in either MIC 
or MBC to triclosan. his alteration in susceptibility was sustained even when triclosan was removed (PX10) in 
terms of both MIC and MBC.
Reduced relative pathogenicity in triclosan exposed isolates. Results obtained from the relative 
pathogenicity assessment are shown in Fig. 2. Overall, 3/5 triclosan adapted S. aureus strains (ATCC 43300, 
Newman and SAR17) exhibited a reduced G. mellonella larvae virulence in comparison to their unexposed coun-
terparts. Pathogenicity for SCV ATCC 43300 (p < 0.001), SAR17 (p < 0.0001) and Newman (p < 0.001) were 
signiicantly reduced when compared to the parent strains, which reverted to pre-exposure levels for Newman 
and ATCC43300 but not for SAR 17 following repeated growth in the absence of triclosan. NCTC 13277 (SCV) 
Gene Protein encoded
S. aureus strains
ATCC43300* Newman* NCTC13277* SAR17* SAR2831
P10 PX10 P10 PX10 P10 PX10 P10 PX10 P10 PX10
fabI Enoyl-ACP reductase G113C — A95V A95V A95V A95V A95V A95V — —
fabD Malonyl CoA-acyl carrier protein transacylase V111D — Q228K Q228K — — — — — —
tcaA Teicoplanin resistance associated membrane — — — — — — — — G373V G373V
NWMN_0826 NADH-dependent lavin oxidoreductase — — H107N H107N — — — — — —
Table 1. Summary mutations and resulting amino acid changes in S. aureus strains ater triclosan exposure. 
P0, bacteria before exposure to triclosan; P10, following ten passages with triclosan exposure; PX10, following 
further ten passages without triclosan exposure. A: alanine, N: asparagine, D: aspartic acid, C: cysteine, Q: 
glutamine, G: glycine, H: histidine, K: lysine. *SCV.
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and SAR2831 (non-SCV) mutants did not exhibit any signiicant diference in pathogenicity when compared to 
their respective parent strain.
Alterations in the S. aureus proteome following triclosan exposure. Proteins exhibiting a 2-fold 
or more signiicant change in expression were investigated for changes in the proteome. Following triclosan 
exposure, 50 proteins were signiicantly (p < 0.05) up-regulated and approximately 55 proteins (p < 0.05) were 
down-regulated in the Newman strain (Fig. 3). While in SAR17, 28 proteins showed increased expression and 20 
showed downregulated expression. ATCC 43300 exhibited the lowest number of protein changes with 8 proteins 
becoming overexpressed and 18 under-expressed. In the non-SCV forming strain (SAR2831), 20 proteins were 
signiicantly up-regulated and approximately 15 proteins were down-regulated (Fig. 3). Protein expression data 
were categorised into eight groups based on protein function or pathway (Fig. 3). Although the majority of altered 
proteins in the PX10 isolates reverted to pre-exposure levels in Newman and ATCC 43300, SAR17 PX10 proteins 
failed to revert to P0 levels.
In terms of virulence associated proteins, in the Newman strain, proteins which play a role in S. aureus vir-
ulence, including response regulator SaeR, Immunodominant Antigen B, Gamma-Hemolysin Component A, 
Immunoglobulin-binding Protein sbi and Leukocidin/Hemolysin Toxin Family S, were down- regulated while 
response regulator protein GraR and drug resistance transporter EmrB/QacA were up-regulated. In SAR17, 
Immunoglobulin-Binding Protein sbi, Immunoglobulin G and Immunodominant Antigen B were upregulated; 
however, /Serine-Rich Adhesin for platelets SraP and Response Regulator Protein GraR were over-expressed. 
None of these proteins showed a signiicant change in ATCC 43300 except for EmrB/QacA that exhibited an 
up-regulation. In the non-SCVs (SAR2831) Gamma Haemolysin and Immunoglobulin G were downregulated.
In Newman and SAR17 (SCVs) as well as the non SCV bacterium SAR2831, fatty acid biosynthesis pro-
teins were upregulated including the triclosan target enzyme enoyl-[acyl-carrier-protein] reductase FabI12 which 
was increased more than 4-fold, 13-fold and 6- fold, respectively. Several further fatty acids synthesis associ-
ated enzymes such as oxoacyl-[acyl-carrier-protein] synthase 2 were also up-regulated in both Newman and 
ATCC43300 strains (3.3 and 2.1-fold, respectively). he SAR17 and Newman SCV exhibited a greater than 2-fold 
increase in expression of oxoacyl-[acyl-carrier-protein] synthase 3 enzyme (FabH). Malonyl CoA-acyl transac-
ylase, which is involved in fatty acid metabolism, was down regulated in both ATCC43300 and Newman ater 
triclosan exposure (5 and 2.4-fold, respectively).
In the Newman strain, expression of stress-associated proteins such as threonine dehydratase II and pyruvate 
formate-lyase-activating enzyme were reduced. Alanine dehydrogenase was down- regulated in Newman, SAR17 
and SAR2831 SCVs. Several peptidoglycan biosynthesis enzymes such as transglycosylase SceD and peptidoglycan 
Figure 1. Colony size of P0 and SCVs (P10) with and without the addition of fatty acids. All P10 SCVs showed 
reduced colony size compared to P0. When the media supplemented with fatty acids, all SCV colony size 
reverted to pre-exposure size (P0). *Signiicant change (p < 0.05) compared to P0 and FA stands for media 
supplemented with fatty acids (Tween 80). Results are means and standard error from representative colonies 
(n = 3).
Passage 
number
S. aureus strains
ATCC43300* NCTC13277 * Newman* SAR17* SAR2831
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
P0 2 (1) 12 (3) 5 (2) 12 (3) 1 13 1 25 6 25
P10 12 (3) 38 (14) 17 (6) 38 (14) 6 (2) 42 (13) 10 (3) 33 (13) 13 50
PX10 12 (3) 33 (13) 12 (3) 42 (13) 13 46 (10) 9 (3) 33 (13) 13 50
Table 2. Minimum inhibitory concentrations and minimum bactericidal concentrations for triclosan before 
(P0), ater exposure to triclosan (P10) and in the absence of the biocide (PX10). See footnote to Table 1. MIC 
and MBC in ive S. aureus isolates (µg/ml); numbers in bracket are standard deviation. Asterisks indicate 
organisms that formed SCV following triclosan exposure. Bold text indicates a statically signiicant diference 
in susceptibility (P < 0.05) compared to P0. Results are means and standard deviation from two separate 
experiments with three technical replicates.
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hydrolase, as well as teichoic acid biosynthesis enzymes and cell membrane proteins were upregulated in the 
Newman SCV. Bifunctional autolysin was over-expressed in all strains except for ATCC43300. Transmembrane and 
cell division proteins were however, less expressed in all SCVs. Similarly, DNA synthesis and replication proteins 
exhibited a reduction in the SCVs as well as the non-SCV triclosan adapted strain. However, DNA binding and 
urease accessory proteins showed up-regulation following triclosan exposure in SCVs Newman and SAR17 and 
SAR2831. Transport proteins showed a variation in expression with the majority being downregulated while those 
associated with amino acids synthesis were overexpressed in all strains. SAR17, ATCC 43300 and SAR2831, showed 
an increase expression of 50 S ribosomal protein while carbamoyl-phosphate synthase was overexpressed in SAR 17. 
Several other cell metabolism proteins also exhibited diferent expression when exposed to triclosan (Supplement 1).
Reduced keratinocyte invasion in triclosan exposed isolates. SCVs, strain Newman (p < 0.001), ATCC 
43300 (p < 0.01) and SAR17 as well as non-SCV SAR2831 (p < 0.05) showed a signiicant reduction in the number 
of recoverable bacteria ater keratinocyte infection when compared to their unexposed counterparts (Fig. 4). In the 
recovered strains (PX10), the number of recoverable Newman and SAR 2831 reverted to unexposed levels however, 
SAR17 PX10 failed to revert to levels comparable to pre-exposure baselines (p < 0.05) (Fig. 4).
Figure 2. Survival curve of four SCVs (NCTC 13277, ATCC 43300, SAR17 and Newman) and SA2831 (non-SCV). 
All SCVs P10 strains exhibited reduced larval lethality compared to P0 with exception of NCTC 13277. ATCC 43300, 
Newman and SAR17 P10 exhibited a signiicant reduction in relative pathogenicity, and PX10 pathogenicity reverted 
to P0 level with exception of SAR17, which remain attenuated even when triclosan was removed (PX10). *Signiicant 
change (p < 0.05) compared to P0. Results are means from three separate experiments.
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Discussion
SCVs are a slow growing subpopulation of bacteria that can form in response to an environmental stresses includ-
ing exposure to certain antibiotics and the biocide triclosan16. he induction of SCV by exposure to triclosan has 
been previously observed10 and we have reported attenuated virulence11 and reduced competitive itness15 in SCV 
induced by this compound. he main purpose of the current investigation was to study the genomic changes 
underlying the formation and reversion of SCV following exposure to triclosan. In pursuing this aim we have 
expanded the panel of test bacteria used in previous studies to include clinical isolates and assessed the correlation 
between an invertebrate virulence assay and a keratinocyte invasion assay to assess the potential implications of 
the triclosan induced SCV. We have used high-resolution proteomics (LC-MS) to further investigate proteomic 
changes in SCV and established the SCV phenotype can be reversed by supplementation with fatty acids.
Five strains of S. aureus including MRSA were repeatedly exposed to sub-lethal concentrations of triclosan 
using a previously validated gradient plate method11. Following ten passages in the presence of triclosan, S. aureus 
strains demonstrated reduced triclosan susceptibility (Table 2) with 4/5 developing the SCV phenotype, sug-
gesting that reduced triclosan susceptibility did not depend on the formation of SCVs. Reductions in triclosan 
sensitivity have been previously observed in other S. aureus SCVs15. At the genomic level a nonsynonymous fabI 
(A95V) mutation was identiied in all the SCVs (Table 1) except for ATCC 43300 that instead exhibited (G113C) 
mutation in the fabI gene. his mutation was sustained when triclosan was removed (PX10) although compensa-
tory mutations were not detected suggesting that with the SCV phenotype is not directly caused by fabI mutation 
or that phenotypic adaptation overcome the physiological efects of the mutation following repeated growth in 
the absence of the antimicrobial.
A (A95V) mutation in the FabI-triclosan binding site17 has been previously reported in triclosan adapted S. 
aureus18 and may contribute to the decrease in triclosan susceptibility (Table 2). According to some previous 
reports, in lipid-rich environments, Gram positive bacteria can overcome fatty acid inhibition by utilizing exog-
enous fatty acids19. We therefore investigated whether the SCV phenotype could be reversed by lipid supplemen-
tation. Interestingly, all SCV colonies increased in diameter to pre-exposure size immediately during growth with 
fatty acid supplementation (Fig. 1), suggesting that triclosan-induced SCVs are deicient in fatty acid synthesis. 
Since triclosan is lipophilic it is notable that reversal of the SCV phenotype occurred in adapted bacteria growing 
in the absence of triclosan and thus, partitioning of the antimicrobial into the supplemental lipids is unlikely to 
be responsible.
Despite their association with persistent infections, reductions in virulence have been previously reported 
in SCVs generated following antibiotic exposure6–9,20 or through sublethal exposure to the biocide triclosan 
in S. aureus ATCC 683511. In the current study, relative pathogenicity was further investigated in a collection 
of triclosan adapted SCV, as well as non-SCV forming strain. In agreement with a previous investigation11, S. 
aureus SCVs exhibited a reduction in relative pathogenicity, evidenced by a reduced G. mellonella virulence when 
Figure 4. Keratinocytes invasion assay of P0, P10 and PX10 in four SCVs (NCTC 13277, ATCC 43300, 
SAR17 and Newman) and SA2831 (Non-SCV). ATCC 43300, SAR17, Newman and SAR2831 P10 exhibited 
a signiicant reduction in recovered bacteria and number of intracellular reverted to unexposed level when 
triclosan was removed. *Signiicant change (p < 0.05) compared to P0. Results are means and standard error 
from three separate experiments with two technical replicates.
Figure 3. Proteins altered in 3 SCVs (Newman, ATCC 43300 and SAR17) and non-SCV (SAR2831) compared 
to P0 categorised based on the function or pathway. Newman exhibited the highest number in protein 
expression alteration while ATCC 43300 and SAR 17 showed changes in 26 and 48 proteins, respectively.
www.nature.com/scientificreports/
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compared to parent strains (Fig. 2). G. mellonella is a useful model to investigate S. aureus pathogenesis and viru-
lence21 because it has an innate immune system22. Moreover, SCVs have been previously associated with recurrent 
and persistent infections and have been shown to exhibit an increased ability to adhere to and invade host cells in 
addition to a reduced antibiotic susceptibility8. To gain further insight into the pathogenic potential of the adapted 
bacteria the ability of triclosan induced S. aureus to invade primary human keratinocytes was assessed, showing 
a reduction in recoverable bacteria in 3/4 SCVs as well as in the non-SCV forming strain (Fig. 4). Reduced 
intracellular persistence may be attributed to down regulation in virulence proteins (immunoglobulin-binding 
protein sbi) as well as a reduced growth rate evidenced by down expression in nucleic acids synthesis and cell 
division proteins (FtsL and FtsZ) (Supplement 1). Moreover, reduction in cell division protein (Supplement 1) 
may account for formation of the SCV phenotype and suggest that the bacteria are defective in cell division which 
correlates with our previously reported TEM analysis15.
SCV persistence has been associated with overexpression of ibronectin-binding protein FnBP8. In the cur-
rent study, low FnBP expression in Newman SCV may explain the reduction in intercellular persistence because 
(FnBP) is crucial for bacterial host cell invasion23. FnBP also participates in adhesion formation (as reviewed by 
Josse et al.)24, therefore, a reduction in FnBP expression in triclosan adapted SCVs may partly explain impaired 
bioilm formation observed previously11. Newman SCV also exhibited low expression in both response regu-
lator SaeR and histidine protein kinase SaeS proteins (Supplement 1), which are regulated by the Sae gene25. 
Sae controls the expression of many virulence genes such as fnbA and hIg, encoding fibronectin-binding 
and gamma-hemolysin proteins, respectively26. hese proteins were down regulated in our Newman strain 
(Supplement 1). Down regulation of sae has been reported in hemB deicient SCVs27, thus attenuated viru-
lence in our Newman SCV may be due to a down regulation in the sae gene. Moreover, 2 /4 SCV exhibited 
down-regulation of immune response proteins, immunodominant antigen B (Supplement 1), which could 
explain the reduced relative pathogenicity in triclosan-induced SCVs.
Proteomic data revealed an upregulation in the triclosan target enzyme FabI in two SCVs as well as the 
non-SCV forming strain (Supplement 1). his may be attributed to non-synonymous mutation in fabI in response 
to triclosan exposure (Table 1). Formation of such a mutation is proposed to be a compensatory mechanism 
whereby S. aureus attempts to compensate for fatty acid depletion28. Moreover, cell membrane proteins exhibited 
up-regulation, such as, EmrB/QacA a membrane fusion elux pump protein, suggesting a possible link between 
elux pump expression and decreased triclosan susceptibility in S. aureus.
Although SAR2831 did not exhibit the SCV phenotype following ten passages of triclosan exposure, there was 
a signiicant reduction in the number of recoverable bacteria in the keratinocyte invasion assay (Fig. 4) as well as 
a down-regulation in ibrinogen-binding protein FIB_STAAE (Supplement 1). Proteins associated with energy 
production (nucleoside diphosphate kinase and ribolavin biosynthesis protein) (Supplement 1) were down reg-
ulated in the non-SCV suggesting that reduced invasion observed in this bacterium might partially be attributed 
to reduced cell metabolism. his suggests that triclosan exposure efects S. aureus pathogenicity regardless of the 
formation of the SCV phenotype potentially through the down-regulation of the proteins. SAR2831 (non-SCV) 
showed a mutation in tcaA (teicoplanin resistance associated membrane protein) despite no diference being 
detected in MICs to teicoplanin before and ater exposure to triclosan (data not shown).
Conclusion
In this investigation, all triclosan-induced SCVs exhibited mutation in fabI, which encodes the Enoyl-
[acyl-carrier-protein] reductase, the major target for triclosan. Triclosan-exposed S. aureus showed reduced path-
ogenicity and keratinocyte invasion regardless of the SCV phenotype, which may be attributed to a reduction in 
the expression of cell adhesion-associated proteins following triclosan adaptation. he potential involvement of 
deiciencies in fatty acid biosynthesis in triclosan SCV was evidenced by the reversal of the phenotype through 
fatty acid supplementation although fabI mutations persisted following reversion.
Materials and Methods
Bacterial strains and growth conditions. Five diferent S. aureus strains were used in this study. Two 
clinical wild type isolates obtained from the Molecular Diagnostics and Personalised herapeutics Unit at the 
University of Hail (Hail, Saudi Arabia). Strain ATCC 43300 (MRSA) was acquired from the American Type 
Culture Collection while strains Newman and NCTC 13277 (MRSA) were supplied by Public Health England 
(Salisbury, UK). Bacteria were maintained on Tryptone Soya Agar (TSA) and Tryptone Soya Broth (TSB) which 
were purchased from Oxoid (Basingstoke, UK) and were sterilised at 121 °C and 15 psi for 15 minutes before use.
Whole genome sequencing and data analysis. DNA extraction and whole genome sequencing (WGS) 
of P0, P10 and PX10 was provided by MicrobesNG using Illumina HiSeq platform. Sequences (length 2 × 250 bp 
paired-end reads) were analysed through several pipelines; starting by using Kraken to identify the closest ref-
erence genome, which conirmed that all sequences are S. aureus. he data were then de novo assembled using 
the SPAdes (http://bioinf.spbau.ru/spades) followed by variant calling against the closest reference genome 
(MRSA252 -UID57839, Newman-UID58839, ECT R2 -UID159389 and T0131-UID159861 for ATCC 43300, 
NCTC 13277, Newman, SAR17 and SAR2831, respectively). Nonsynonymous mutations were identiied by com-
paring P10 and PX10 genomes to the untreated parent isolate (P0).
Exposure to sub-lethal concentrations of triclosan and fatty acid supplementation. Reproducible 
concentration gradients of triclosan (100 µg/ml to 10 mg/ml) were spread on TSA using a Wasp II spiral plater 
(Don Whitley, Shipley, United Kingdom)11,15 and allowed to dry for 30 min at room temperature. Following this, 
overnight suspensions of S. aureus were radially inoculated onto plates in triplicate and incubated for 4 days 
(37 °C). Ater 4 days, a heavy inoculum was taken from the edge of the sub-lethal zone and inoculated onto a fresh 
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plate containing the same (or higher) concentration of triclosan. his was passaging process was repeated a further 
ten times to produce P10. Following this, a further ten passages were performed in the absence of triclosan to create 
PX10. All stocks were cryopreserved at −80 °C for further testing. For the fatty acid supplementation experiment, 
MHA was supplemented with Tween 80 (0.1%) and plates were incubated at 37 °C for 24 h. Ater sample incuba-
tion, the plates were photographed, and images were imported into the ImageJ sotware. hree random colonies 
diameter were measured, and data presented as a percentage to pre-exposure strain (P0). Parent strains were also 
incubated with and without fatty acids to ensure that the increase in the colony size is not due to a simple nutri-
tional response.
Minimum Inhibitory Concentrations and Minimum Bactericidal Concentrations. MICs were 
determined using the broth microdilution assay as described previously29. Briely, overnight bacterial cultures 
were diluted in TSB to an OD600 of 0.8 and then further diluted 1: 100 in TSB. Adjusted cultures were then 
transferred to a 96 well microtitre plate containing doubling dilutions of triclosan. he microdilution plates were 
incubated at 37 °C for 24 h. he MIC was deined as the lowest concentration of the antimicrobial that inhibits the 
bacterial growth. Bacterial growth was determined by visual inspection for turbidity in the well. Aliquots (5 µL) 
were transferred from wells showing no growth and placed into sterile TSA plates and incubated at 37 °C (24 h) to 
measure MBCs. MBC was deined as the lowest concentration of the antimicrobial required to show no growth 
ater 4 days of incubation.
Galleria mellonella pathogenesis assay. he pathogenesis assay was adapted from11. Final stage G. mel-
lonella larvae were purchased from Live Foods Direct (Sheield, United Kingdom) and stored in dark for a max-
imum of 7 days. 10 larvae (15–25 mm in length) were selected for each condition (P0, P10 and PX10). Overnight 
S. aureus cultures were grown in TSB and washed twice in sterile Phosphate Bufer Solution (PBS) then diluted to 
OD600 0.3. Hamilton syringe were used to injected hemocele larvae through let proleg with the washed bacterial 
suspension (5 µl) (0.8–2.6 × 106 CFU/Larvae which conirmed colony count in TSA). he syringe was washed 
by ethanol (100%) twice before injecting another group. Each group (10 larvae) were placed in sterile petri dish 
and incubated at 37 °C. A control group (not injected) and a PBS injected group were also incubated as a negative 
control. Survival of each group were recorded daily for 6 days and larvae considered dead when appear black or 
no response seen when touch. he experiment was performed three independent times and if two or more of the 
control larvae died, the experiment was repeated again. Results were presented in survival curve and log-rank test 
were calculated using Prism v.7 (www.graphpad.com/).
Keratinocyte invasion assay. Invasion assays were performed as described by30. Normal primary human 
epidermal keratinocytes (NHEK) were purchased from Promocell (Germany) and were grown in 24 well-plate 
containing keratinocyte growth medium-2 (1 ml) (Promocell, Germany) until 90% conluence (3–5 × 105 cells/
well). Overnight S. aureus suspension was diluted in keratinocyte growth medium-2 to OD600 0.4 (1–2.5 × 10
8 
CFU/ml). Bacteria were added at a keratinocyte: bacteria ratio of 1:100 and incubated for 2 h at 37 °C. 
Keratinocytes were washed twice with sterile PBS (1 ml) followed by addition of gentamicin (100 µl/ ml) and 
lysostaphin (10 µl/ml) to kill any unattached or loosely adhered bacteria. To lyse keratinocytes, distilled water 
(100 µl) and trypsin (100 µl) were added and serial dilutions of the lysed suspensions were plated on TSA, before 
incubation overnight at 37 °C and determining of remaining viable bacteria. Assay was performed in triplicate 
for each isolate (P0, P10 and PX10) and student t-test was used to determine signiicance between recoverable 
levels of bacteria.
Protein extraction and preparation for mass spectrometry. All chemicals used were from Sigma 
Aldrich (Dorset, UK) unless otherwise stated. SCV that exhibited attenuated relative pathogenicity and sig-
niicant reduction in recovered bacteria, were included for further protein analysis. Six replicates of P0, P10 
and PX10 were grown in TSB overnight (37 °C, 100 Samples were prepared for prepared for mass spectrometry 
using a modiied Filter-aided sample preparation (FASP) method31 with the following modiications: he cul-
tures were pelleted by centrifugation at 4000 rpm for 10 minutes, the supernatant was decanted and the pellet 
was washed twice in PBS containing 1% protease inhibitors. he washed pellet was resuspended in 1 mL of PBS 
with lysostaphin (10% v/v) and kept on ice for 15 minutes. he washed cells were transferred to Zirconia/Silica 
bead-containing tubes (Stratech Scientiic, UK) and lysed in a FastPrep 120 (hermo Scientiic, UK) at 40 rpm for 
20 seconds, with 20 seconds cooling, for a total of 3 cycles. Sodium Dodecyl Sulphate (SDS) (1%) and dithiothrei-
tol (DTT) were added to a inal concentration of 1% (w/v) and 50 mM respectively. he samples were incubated 
at 90 °C for 5 minutes. he lysate was centrifuged at 10,000 g for 5 minutes and the supernatant was transferred to 
clean tube and the protein concentration was measured using a Direct Detect Spectrometer (Merck Millipore).
For FASP, clariied lysate (25 µg) was added to 100 µL of wash bufer (8 M urea, 0.1 Tris-HCl (pH 8.5) with 15 mM 
DTT) and washed twice in a 30 kDalton ilter (Merck Millipore). To alkylate the sample, 50 µL of bufer (8 M urea, 
0.1 M Tris-HCl (pH 8.5) with 0.05 M iodoacetamide) was added to the ilter and the sample was incubated in dark-
ness at room temperature for 30 minutes. he ilters were washed twice with washing bufer 1 followed by a further 
two washes of washing bufer 2 (6 M urea, 0.1 Tris-HCl (pH 8.5) with 25% deionised water) before dilution in 
50 mM Tris-HCl (pH 8.5) to bring the urea concentration to 1 M. Samples were digested by the addition of trypsin 
at a protein: enzyme ratio of 1:100 and incubated overnight at 37 °C. Ater digestion, peptides were collected by 
centrifugation at 4000 g at 20 °C for 15 minutes and the iltration units were washed once with washing bufer 2 and 
subsequently with two washes of 40 mM ammonium bicarbonate. Peptide samples were transferred to 96 well plate 
with 0.2 µM PVDF membrane (Corning) and desalted with OLIGO R3 reversed-phase media (Applied Biosystems). 
Desalted peptides were dried down and resuspended in 5% acetonitrile with 0.1% formic acid and analysed by 
LC-MS/MS using an UltiMate® 3000 Rapid Separation LC (RSLC, Dionex Corporation, Sunnyvale, CA) coupled 
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to an Orbitrap Elite (hermo Fisher Scientiic, Waltham, MA) mass spectrometer. Peptide mixtures were separated 
using a gradient from 92% A (0.1% FA in water) and 8% B (0.1% FA in acetonitrile) to 33% B, in 44 min at 300 nL 
min-1, using a 250 mm × 75 µm i.d. 1.7 mM BEH C18, analytical column (Waters). Peptides were selected for frag-
mentation automatically by data dependant analysis (DDA).
he acquired MS data was analysed using Progenesis LC-MS (v4.1, Nonlinear Dynamics). he retention times 
in each sample were aligned using one LC-MS run as a reference, then the “Automatic Alignment” algorithim was 
used to create maximal overlay of the two-dimensional feature maps. Features with charges ≥+ 5 were masked 
and excluded from further analyses, as were features with less than 3 isotope peaks. he resulting peak lists were 
searched against the UniProt database with Staphylococcus aureus (Strain Newman) sequences included (UniProt, 
download date: 2016/02/26) using Mascot v2.5.1, (Matrix Science). Search parameters included a precursor toler-
ance of 5 ppm and a fragment tolerance of 0.5 Da. Enzyme speciicity was set to trypsin and one missed cleavage 
was allowed. Carbamidomethyl modiication of cysteine was set as a ixed modiication while methionine oxi-
dation was set to variable. he Mascot results were imported into Progenesis LC-MS for annotation of peptide 
peaks. Proteins exhibiting 2 or more-fold signiicant changes (at a p < 0.05) were included in the study.
Data availability. All data generated or analysed during this study are included in this published article (and 
its Supplementary ile).
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